Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified-release Hydrocortisone in Adrenal Insufficiency
NCT00915343Phase 3Completed
- Sponsor
- Takeda
- Start
- Aug 2007
- Primary completion
- Jul 2008
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of hydrocortisone in primary adrenal insufficiency (PAI), sponsored by Takeda. Started Aug 2007; status: completed.
02
Drugs
hydrocortisone
03
Conditions
primary adrenal insufficiency (PAI)
Beyond the preview
Go deeper on NCT00915343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00915343.